DeutschNewstral
Article
jdsupra.com on 2019-11-19 17:57
FDA Approves Pfizer’s Adalimumab Biosimilar ABRILADA
Related news
- China NMPA Approves Adalimumab Biosimilarjdsupra.com
- Sandoz Obtains FDA Approval for Adalimumab Biosimilarjdsupra.com
- FDA Approves Pfizer’s EPO Biosimilarjdsupra.com
- FDA Approves 25th Biosimilarjdsupra.com
- FDA Approves Boehringer Ingelheim’s Adalimumab Biosimilarjdsupra.com
- FDA Approves Mylan’s Biosimilar of HUMIRA (Adalimumab)jdsupra.com
- FDA Approves Coherus’ Adalimumab Biosimilar YUSIMRY™jdsupra.com
- FDA Approves Sandoz’s Biosimilar Pegfilgrastimjdsupra.com
- FDA Approves First Rituximab Biosimilarjdsupra.com
- FDA Approves Celltrion’s Trastuzumab Biosimilarjdsupra.com
- Teva and Alvotech’s Adalimumab Biosimilar Receives Interchangeable Status at FDAjdsupra.com
- FDA Approves Samsung Bioepis’s Trastuzamab Biosimilarjdsupra.com
- Celltrion Files IND with FDA for Adalimumab Biosimilarjdsupra.com
- FDA approves a fourth biosimilar of HERCEPTINjdsupra.com
- EC Approves Amgen’s Biosimilar Adalimumabjdsupra.com
- IFDA Approves Pfizer’s COVID-19 Vaccineisubengal.com
- FDA Approves Second Pegfilgrastim Biosimilar, a First for Coherusjdsupra.com
- FDA Approves First Biosimilar: Sandoz’s Zarxio®jdsupra.com
- European Biosimilar Approval Updates: Adalimumab, Pegfilgrastimjdsupra.com
- Sandoz Launches Adalimumab Biosimilar in Spainjdsupra.com